Segment Information

12 Months Ended

Sep. 30, 2016

Segment Information [Abstract]

Segment Information

16.Segment Information

During fiscal 2014, the Company changed the presentation of its reporting segments to separately disclose certain ‘corporate expenses’ that had previously been reported within the Radiation Measurement segment. As a result, the current segment disclosures reflect three reporting segments (Radiation Measurement, Medical Physics and Medical Products) and one functional group  (Corporate).  As disclosed in Note 4 to the Consolidated Financial Statements, Medical Products was divested in May 2016 which resulted in a reduction in revenues, operating income, depreciation and amortization and the elimination of assets for the year ended September 30, 2016.  The factors for determining the reportable segments reflect specific markets and the products and services offered combined with the nature of the individual business traits, as well as key financial information reviewed by management.

The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure. These services are provided internationally primarily to hospitals, medical and dental offices, universities, national laboratories, and nuclear facilities. Radiation Measurement activities include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. In addition to providing analytical services, the Radiation Measurement segment sells dosimetry detectors and reading equipment.

The Medical Physics segment provides therapeutic and imaging physics services to domestic hospitals and radiation therapy centers. Service offerings include clinical physics support, equipment commissioning, accreditation support and imaging equipment testing. These professional services are provided to customers on-site by skilled physicists.

The Medical Products segment provided medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures. Medical products ranged from consumables used with MRI, CT, and mammography technologies to highly engineered passive reflective markers used during image guided surgery procedures.

The Company primarily evaluates performance of the individual segments based upon, among other metrics, segment operating income or loss. Segment operating income or loss is segment revenues less segment cost of sales and segment selling, general and administrative expenses. Corporate expenses for shared functions, including corporate management, corporate finance and human resources, are recognized in the Corporate functional group. In addition, acquisition and reorganization costs are not allocated to the segments. Information about net other income, including interest income and expense, and income taxes is not provided at the segment level. As the Company’s business model evolves in increased complexity, management may determine it necessary to change this reporting practice to reflect any appropriate allocations.

The following tables summarize financial information for each reportable segment for the years ended September 30:

(Dollars in Thousands)	2016		2015		2014
Revenues by segment:
Radiation Measurement	$	104,203	$	105,978	$	113,556
Medical Physics		39,234		35,449		32,213
Medical Products		5,802		9,887		9,293
Consolidated revenues	$	149,239	$	151,314	$	155,062
	2016		2015		2014
Operating income (loss) by segment:
Radiation Measurement	$	37,853	$	35,641	$	38,231
Medical Physics		3,201		3,126		1,827
Medical Products (1)		1,063		1,534		(62,572)
Corporate		(15,476)		(16,602)		(17,473)
Consolidated operating income (loss)	$	26,641	$	23,699	$	(39,987)
	2016		2015		2014
Depreciation and amortization by segment:
Radiation Measurement	$	9,560	$	10,345	$	10,250
Medical Physics		1,038		1,089		1,085
Medical Products		474		878		2,580
Consolidated depreciation and amortization	$	11,072	$	12,312	$	13,915

(1)Includes goodwill and other intangible assets impairment charge of $62,188 in fiscal 2014.

(Dollars in Thousands)	2016		2015
Segment assets:
Radiation Measurement	$	160,560	$	142,850
Medical Physics		43,174		43,677
Medical Products		-		48,308
Eliminations		(12,918)		(26,091)
Consolidated assets	$	190,816	$	208,744